And our results identified UNC0379, a KMT5A selective inhibitor, cooperates with YAP signaling inhibition to prevent breast cancer progression and metastasis, which may help overcome the narrow therapeutic index of single treatment strategy. This evidence concerns the gene KMT5A and breast cancer.